Price $18.72 |
Market Cap
354.2M
|
Sector Health Care |
Div. Growth
10.00%
|
|
P/E
50.3
|
P/B
11.38
|
P/S
12.11
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
216.1
|
Op. Cash Flow
7.9K
|
FCF
0.0
|
|
Op. Margin
34.20%
|
Net Margin
29.90%
|
ROE
31.00%
|
ROI
22.50%
|
|
ROA
21.60%
|
EPS Growth
60.40%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
| Quorum Health Corp (QHC) | $3.95 | - | - | 140.9M | Strong Buy |
| Integer Holdings Corp (ITGR) | $82.77 | - | - | 2.7B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.44 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.30 | - | - | 122.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
